396 related articles for article (PubMed ID: 18698022)
21. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
22. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
Ahmed A; Gilbert-Barness E; Lacson A
Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
[TBL] [Abstract][Full Text] [Related]
24. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.
Khan IU; Reppich R; Beck-Sickinger AG
Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650
[TBL] [Abstract][Full Text] [Related]
25. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y receptors in renal cell carcinomas and nephroblastomas.
Körner M; Waser B; Reubi JC
Int J Cancer; 2005 Jul; 115(5):734-41. PubMed ID: 15704095
[TBL] [Abstract][Full Text] [Related]
27. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y Y1 receptor in human dental pulp cells of noncarious and carious teeth.
El Karim IA; Lamey PJ; Linden GJ; Lundy FT
Int Endod J; 2008 Oct; 41(10):850-5. PubMed ID: 18699789
[TBL] [Abstract][Full Text] [Related]
29. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation.
George E; Niehans GA; Swanson PE; Strickler JG; Singleton TP
Arch Pathol Lab Med; 1992 Oct; 116(10):1033-5. PubMed ID: 1358045
[TBL] [Abstract][Full Text] [Related]
34. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
35. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
Bjørnebekk A; Mathé AA; Brené S
Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
[TBL] [Abstract][Full Text] [Related]
36. Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas.
Wittmann W; Loacker S; Kapeller I; Herzog H; Schwarzer C
Neuroscience; 2005; 136(1):241-50. PubMed ID: 16198492
[TBL] [Abstract][Full Text] [Related]
37. Assessment of muscarinic and nicotinic acetylcholine receptor expression in primitive neuroectodermal tumor/ewing family of tumor and desmoplastic small round cell tumor: an immunohistochemical and Western blot study of tissue microarray and cell lines.
Schlauder SM; Steffensen TS; Morgan M; Letson DG; Pledger WJ; Ma L; Bui MM
Fetal Pediatr Pathol; 2008; 27(2):83-97. PubMed ID: 18568996
[TBL] [Abstract][Full Text] [Related]
38. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
40. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]